Ranbaxy receives FDA OK for ramipril capsules
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has received US FDA approval to manufacture and market ramipril capsules 5mg and 10mg, generic versions of King Pharmaceuticals' cardiovascular drug, Altace.